Scientists at the University of Pittsburgh School of Medicine announced Thursday that they have developed a potential vaccine for COVID-19.
The vaccine, which is transmitted through a small skin patch, will allow the user to develop immunity against the new coronavirus which is causing a global pandemic.
“We knew exactly where to fight this new virus,” said Dr. Andrea Gambotto, associate professor of surgery at the Pitt School of Medicine and lead co-author of groundbreaking research. “This is why it is important to fund research on vaccines. You never know where the next pandemic will come from. “
The Pittsburgh coronavirus vaccine is called PittCoVacc. It has shown positive results when tested in mice and is awaiting approval from the Food and Drug Administration (FDA).
According to Pitt scientists, the vaccine will enter the human testing phase in the coming months.
“Testing in patients would typically take at least a year and probably longer,” said lead co-author Louis Falo, MD, Ph.D., who is professor and president of dermatology at Pitt’s School of Medicine and at ‘UPMC. “This particular situation is unlike anything we’ve ever seen, so we don’t know how long the clinical development process will take. The recently announced revisions to normal processes suggest that we may be able to progress more quickly. “
For more information, click here.